An Indiana-based pharmaceutical giant told federal regulators Monday that an “initial set of covered entities” have five days to comply [...] …
Articles by : Luke Zarzecki, National Correspondent
Virginia Gov. Abigail Spanberger (D) recently vetoed a bill that would have established a state prescription drug affordability advisory panel [...] …
Please Login or Become a Paid Subscriber to View this Content
Provider-Funded Paper Estimates 340B Claims Data, Rebate Model Could Bring Billions to Drug Industry
A new provider-funded paper argued that drugmakers could gain billions of dollars annually by requiring 340B covered entities to use [...] …
Please Login or Become a Paid Subscriber to View this Content
340B drug pricing program stakeholders—from both sides of the debate over its future—cheered on the May 14 addition of an [...] …
Please Login or Become a Paid Subscriber to View this Content
Two major pharmaceutical companies exempted certain states and reversed exemptions in others, following court rulings, threats of enforcement actions and [...] …
Please Login or Become a Paid Subscriber to View this Content
An Arkansas Republican, who has historically supported 340B providers, announced Friday that he has joined the bipartisan U.S. Senate working [...] …
Please Login or Become a Paid Subscriber to View this Content
A 340B hospital trade group and an oncology physician organization recently submitted competing letters to the editor in response to [...] …
Please Login or Become a Paid Subscriber to View this Content
Exclusive
Novo Nordisk Says it Won’t Require Tennessee Providers to Report Claims Data Following AG Warning
A major drugmaker recently told a Tennessee official that it will not require state providers to submit 340B claims data [...] …
Please Login or Become a Paid Subscriber to View this Content
WSJ Editorial Board Op-Ed Points to North Dakota Judge’s Contract Pharmacy Ruling, Calls 340B ‘Scam’
A major newspaper’s editorial board recently highlighted a federal judge’s ruling against North Dakota’s contract pharmacy access law to denounce [...] …
Please Login or Become a Paid Subscriber to View this Content
Two economists with previous ties to a pharmaceutical industry-funded patient advocacy group recently argued that classifying 340B as a tax [...] …